Patents by Inventor Ali Kuraishy

Ali Kuraishy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function
    Patent number: 9433686
    Abstract: The invention provides methods for reducing growth and/or metastasis of androgen-independent (castration resistant) prostate cancer in a tissue in an animal. In one embodiment the method comprises administering to the animal a therapeutically effective amount of a compound that reduces the number of B cells, and/or the function of B cells, in the tissue. In yet another embodiment, the invention provides methods for reducing androgen-induced growth of prostate epithelial cells in prostate tissue in an animal. In one embodiment, the method comprises administering to the animal a therapeutically effective amount of a compound that reduces the number of B cells, and/or the function of B cells, in the tissue.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: September 6, 2016
    Assignee: The Regents of the University of California
    Inventors: Michael Karin, Massimo Ammirante, Ali Kuraishy
  • Methods for Inhibiting Prostate Cancer
    Publication number: 20140086918
    Abstract: The invention provides methods for reducing growth and/or metastasis of androgen-independent (castration resistant) prostate cancer in a tissue in an animal. In one embodiment the method comprises administering to the animal a therapeutically effective amount of a compound that reduces the number of B cells, and/or the function of B cells, in the tissue. In yet another embodiment, the invention provides methods for reducing androgen-induced growth of prostate epithelial cells in prostate tissue in an animal. In one embodiment, the method comprises administering to the animal a therapeutically effective amount of a compound that reduces the number of B cells, and/or the function of B cells, in the tissue.
    Type: Application
    Filed: January 31, 2012
    Publication date: March 27, 2014
    Applicant: The Regents of the University of California
    Inventors: Michael Karin, Massimo Ammirante, Ali Kuraishy